Brazil means business - but not at any cost
This article was originally published in Clinica
Executive Summary
The Brazilian healthcare surveillance agency, Anvisa, is to have a new role as market regulator, heading a root-and-branch review of the medical technology industry. The move is in response to evidence that device price increases have far exceeded inflation in recent years.